TrialFrontiers in immunology2022

Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19.

Lyn R Frumkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.